Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Číst více
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Číst více
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Číst více
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Číst více
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Číst více
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Číst více
Odyssey Outcomes - PVD Sub-analysis

Odyssey Outcomes - PVD Sub-analysis

Číst více
Odyssey Outcomes - PVD Sub-analysis

Odyssey Outcomes - PVD Sub-analysis

Číst více
Odyssey Outcomes - PVD Sub-analysis

Odyssey Outcomes - PVD Sub-analysis

Číst více
Odyssey Outcomes - PVD Sub-analysis

Odyssey Outcomes - PVD Sub-analysis

Číst více
Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Číst více
Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Číst více